Articles On Telix Pharmaceuticals (ASX:TLX)
Title | Source | Codes | Date |
---|---|---|---|
Telix Urology Innovation Showcase to be held at The Yale Club, New York City
MELBOURNE, Australia and INDIANAPOLIS, June 21, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today provides an outline agenda for the Company’s briefing session for shareholders to be held on Wednesday... |
FNArena | TLX | 10 months ago |
Check Up: Brisbane based Vaxxas set to disrupt market with game-changing, needle-free vaccines
Brisbane-based biotech Vaxxas is working on needles-free vaccine The Nanopatch is said to be a “game changer” We look at the best and worst performing ASX biotechs over the past month The world is anticipating a “game changer” as Brisba... |
Stockhead | TLX | 10 months ago |
First patient dosed in study of TLX250-CDx exploring indication expansion
Telix (ASX:TLX) has announced that the first patient has been dosed in a global Phase 2 study of its imaging agent TLX250-CDx (89Zr-DFO-girentuximab). |
BiotechDispatch | TLX | 10 months ago |
TMH Spotlight: Iceni Gold (ASX:ICL) discovers further gold at Guyer target area, Telix Pharmaceuticals (ASX:TLX) doses first patient in phase two cancer study
The ASX was trading positively at midday, up almost 0.7 per cent. Most sectors secured gains, with healthcare leading the pack, up nearly two per cent at midday. In ASX news, Iceni Gold (ICL) has made further gold finds along the 15-... |
themarketherald.com.au | TLX | 10 months ago |
Telix Pharmaceuticals (ASX:TLX) doses first patient in phase two cancer study
Telix Pharmaceuticals (TLX) doses the first patient for its phase II Starburst study for treating a broad range of cancers The study will look to test the effects of its carbonic anhydrase (CAIX) targeting PET/CT imaging agent TLX250-CD... |
themarketherald.com.au | TLX | 10 months ago |
First Patient Dosed in Phase II STARBURST Study of TLX250-CDx Exploring Indication Expansion
MELBOURNE, Australia, June 19, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the first patient has been dosed in a Phase II study of the Company’s carbonic anhydrase- (CAIX)-targeti... |
FNArena | TLX | 10 months ago |
Here are the top 10 ASX 200 shares today
The S&P/ASX 200 Index (ASX: XJO) has ended the trading week on a very high high this Friday. Not only did today’s session mark the ASX’s fifth straight day of gains in a row, but it also left the index at a three-week high. The ASX... |
Motley Fool | TLX | 10 months ago |
Telix Briefing: Innovation in Urology to Feature Key Opinion Leaders in Prostate and Kidney Cancer
June 21, 2023, at The Yale Club, New York City Featured speakers and Key Opinion Leaders include: Dr Christian Behrenbruch, Dr Colin Hayward, Kevin Richardson, Dr Brian Shuch and Dr Scott Tagawa Topics include Telix’s urologic pipeline,... |
FNArena | TLX | 10 months ago |
Here are the top 10 ASX 200 shares today
The S&P/ASX 200 Index (ASX: XJO) has closed after another positive session this Wednesday. Following the ASX 200‘s late return to trading this week (thanks to the King’s Birthday holiday), the index ended up adding a healthy 0.32% to... |
Motley Fool | TLX | 10 months ago |
Here are the top 10 ASX 200 shares today
After a shaky start in the red this morning, the S&P/ASX 200 Index (ASX: XJO) ended up closing higher on Tuesday afternoon. The ASX 200 finished the day at 7,138.9 points, a gain of 0.23% These gains might have been helped by last week... |
Motley Fool | TLX | 10 months ago |
Telix opens European radiopharmaceutical production facility
Telix (ASX:TLX) has officially opened its radiopharmaceutical production facility in Brussels South (Seneffe), in the Wallonia region of Belgium. |
BiotechDispatch | TLX | 10 months ago |
Telix Pharmaceuticals opens $21m nuclear medicine facility in Belgium
Australia’s second-largest biotechnology company by revenue behind CSL (ASX: CSL), Telix Pharmaceuticals (ASX: TLX) opened a world-class radiopharmaceutical nuclear medicine facility in Belgium on Thursday. The $21 million facility will se... |
businessnewsaustralia.com | TLX | 10 months ago |
Telix Opens European Radiopharmaceutical Production Facility
Telix has unveiled its new, state-of-art radiopharmaceutical facility in Brussels South as part of its first stage investment of €14.1 million ($A21.2 million) Located in Walloon’s ‘Radiopharma Valley’ the facility will be a central... |
FNArena | TLX | 10 months ago |
Telix to Present at Jefferies Healthcare Conference
MELBOURNE, Australia, June 6, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today advises that Dr Christian Behrenbruch, Managing Director and Group CEO, will be presenting at the Jefferies Healthcare C... |
FNArena | TLX | 10 months ago |
TMH Market Close: ASX200 closes the week in the green
The final day of the trading week saw the ASX finish in the green up 0.48 per cent. This comes after the US senate voted to suspend the country’s debt ceiling until 2025, avoiding a potentially catastrophic default. In the green U... |
themarketherald.com.au | TLX | 10 months ago |
Here are the top 10 ASX 200 shares today
After starting the day off on the wrong foot, the S&P/ASX 200 Index (ASX: XJO) tumbled even further this afternoon to close the day 1.48% lower at 7,102.8 points. The apparent driver of its tumble was the latest Aussie inflation figur... |
Motley Fool | TLX | 10 months ago |
Here are the top 10 ASX 200 shares today
The S&P/ASX 200 Index (ASX: XJO) traded in the red for much of Tuesday, ending the session 0.11% lower at 7,209.3 points. It came on the back of various public holidays in the United States, the United Kingdom, and Germany on Monday. T... |
Motley Fool | TLX | 10 months ago |
Why ALS, IDP Education, Predictive Discovery, and Telix shares are falling
It has been a great start to the week for the S&P/ASX 200 Index (ASX: XJO). In afternoon trade, the benchmark index is up 1.1% to 7,231.2 points. Four ASX shares that have failed to follow the market higher today are listed below. Her... |
Motley Fool | TLX | 10 months ago |
Telix to Host Briefing with U.S. Leadership Team and Key Opinion Leaders to Highlight Innovation in Urology
June 21, 2023, at The Yale Club, New York City The Company will showcase its urologic pipeline, development of novel therapeutics, imaging agents and technologies that aim to harness the power of targeted radiation at every step of the p... |
FNArena | TLX | 10 months ago |
Here are the top 10 ASX 200 shares today
The S&P/ASX 200 Index (ASX: XJO) tumbled on Thursday, falling 1.05% to close at 7,138.2 points. The marketâs suffering came amid continued concerns of the United Statesâ rapidly approaching debt ceiling, as my Fool colleague Bernd... |
Motley Fool | TLX | 11 months ago |
The Overnight Report: Bouncing Off The Ceiling
World Overnight SPI Overnight 7241.00 – 35.00 – 0.48% S&P ASX 200 7259.90 – 3.40 – 0.05% S&P500 4145.58 – 47.05 – 1.12% Nasdaq Comp 12560.25 – 160.53 – 1.26% DJIA 33055.51 – 231.07 – 0.69% S&P500 VIX 18.53 + 1.32 7... |
FNArena | TLX | 11 months ago |
Here are the top 10 ASX 200 shares today
After spending all day in the green, the S&P/ASX 200 Index (ASX: XJO) posted a last-minute fall on Tuesday, dropping 0.05% to close at 7,259.9 points. It followed a mixed performance on Wall Street overnight. The Dow Jones Industrial... |
Motley Fool | TLX | 11 months ago |
3 ASX 200 stocks rocketing to never-before-seen heights today
The S&P/ASX 200 Index (ASX: XJO) is in the green on Tuesday, thanks in part to three stocks each soaring to new all-time record highs. So, whatâs been going right for the trio lately? Letâs take a look. 3 ASX 200 shares reaching re... |
Motley Fool | TLX | 11 months ago |
Here are the top 10 ASX 200 shares today
The S&P/ASX 200 Index (ASX: XJO) spent Tuesday in the red, closing the day 0.45% lower at 7,234.7 points. And there were plenty of sectors weighing it down. The S&P/ASX 200 Consumer Staples Index (ASX: XSJ) was its worst performer.... |
Motley Fool | TLX | 11 months ago |
3 shares to buy from the 3 hottest ASX sectors right now
Maybe you are sick of hearing this, but it doesn’t make it any less true: it’s a turbulent time for ASX shares at the moment. With much of the world still struggling with both high inflation and steep interest rate rises, it’s touch-and-go... |
Motley Fool | TLX | 11 months ago |
Here are the top 10 ASX 200 shares today
The S&P/ASX 200 Index (ASX: XJO) slipped lower once more on Thursday, falling 0.05% to close at 7,251.9 points. Weighing it down was the S&P/ASX 200 Materials Index (ASX: XMJ), which slumped 0.4% despite a ripper performance from... |
Motley Fool | TLX | 11 months ago |
Here are the top 10 ASX 200 shares today
The S&P/ASX 200 Index (ASX: XJO) slumped on Wednesday, dropping 0.12% to close at 7,255.7 points. Its day in the red came on the back of the 2023 federal budget, delivered on Tuesday night. It included $14.6 billion of spending aimed a... |
Motley Fool | TLX | 11 months ago |
3 ASX 300 shares that turned $5,000 into $59,000 or much more in 5 years
S&P/ASX 300 Index (ASX: XKO) shares have returned an average of 18.8% over the past five years. Of course, some stocks have exceeded those gains while others have lost value over this time. Below, we look at three ASX 300 shares that w... |
Motley Fool | TLX | 11 months ago |
Telix to supply Bayer with Illuccix for global late-stage prostate cancer study
Telix (ASX:TLX) has agreed with Bayer to supply its Illuccix for a Phase 3 ARASTEP study investigating the efficacy of the German company's Nubeqa (darolutamide) plus androgen deprivation therapy in hormone-sensitive prostate cancer... |
BiotechDispatch | TLX | 11 months ago |
Telix to Supply Bayer with Illuccix® for Global Phase III Prostate Cancer Study
MELBOURNE, Australia, May 8, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has entered into an agreement with Bayer AG (Bayer) to supply Illuccix® (TLX591-CDx, kit for the prepar... |
FNArena | TLX | 11 months ago |
Telix to Supply Bayer with Illuccix® for Global Phase III Prostate Cancer Study, including Japanese Sites
MELBOURNE, Australia and KYOTO, Japan, May 8, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has entered into an agreement with Bayer AG (Bayer) to supply Illuccix® (TLX591-CDx, k... |
FNArena | TLX | 11 months ago |
Why has the Telix Pharmaceuticals share price rocketed 53% in a month?
ASX 200 healthcare share Telix Pharmaceuticals Ltd (ASX: TLX) has had a stellar month. The Telix Pharmaceuticals share price has soared 53% from $7.01 at market close on 3 April to $10.745 at the time of writing. For perspective, the S&am... |
Motley Fool | TLX | 11 months ago |
Here are the top 10 ASX 200 shares today
The S&P/ASX 200 Index (ASX: XJO) plummeted on Tuesday, dropping 0.92% to finish the session at 7,267.4 points. Its day in the red came amid the Reserve Bank of Australia (RBA) boardâs May meeting, wherein it hiked interest rates once... |
Motley Fool | TLX | 11 months ago |
First Patients in Canada Imaged with Illuccix®: Now Commercially Available Nationwide
MELBOURNE, Australia, May 2, 2023 /PRNewswire/ – Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces first patients have been imaged in Canada with its commercially available prostate cancer imaging agent, Illucc... |
FNArena | TLX | 11 months ago |
ASX Large Caps: Shares jump after guidance upgrades by Origin, Judo and Transurban
The ASX jumped half a percent, tracking moves in New York on Friday Three major decisions by central banks this week Judo Capital upgrades its net interest margin guidance for H2 The ASX 200 index rose to by 0.5% on Tuesday as it track... |
Stockhead | TLX | 11 months ago |
Why Perenti, Pointsbet, ResMed, and Telix shares are rising today
The S&P/ASX 200 Index (ASX: XJO) has started the week in a positive fashion. In afternoon trade, the benchmark index is currently up 0.5% to 7,343.3 points. Four ASX shares that are climbing more than most today are listed below. Her... |
Motley Fool | TLX | 11 months ago |
Telix Pharmaceuticals (ASX:TLX) reports fresh “positive” data from kidney cancer imaging trial
Telix Pharmaceuticals (TLX) reveals new “positive” results from its phase III ZIRCON study of its TLX250-CDx imaging agent in clear cell renal cell carcinoma (ccRCC) TLX says the study shows the “high value” of its agent in detecting cc... |
themarketherald.com.au | TLX | 11 months ago |
ZIRCON Phase III Kidney Cancer Imaging Study Presented at AUA: New Data Confirms Efficacy in Masses 2cm or Smaller
MELBOURNE, Australia, May 1, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces additional positive results from its completed pivotal Phase III ZIRCON study of TLX250-CDx (89Zr-DFO-girentuxi... |
FNArena | TLX | 11 months ago |
Check Up: Healthcare is ripe for AI disruption, and Telix Pharma’s first $100m quarterly sales
Artificial intelligence is set to disrupt the healthcare sector AI could also help in drugs discovery Telix delivers first quarterly revenue of $100 million Moody’s Analytics’ chief economist, Mark Zandi, said the healthcare industry’s... |
Stockhead | TLX | 11 months ago |
Telix Pharmaceuticals (ASX:TLX) bolsters AI development through Dedicaid acquisition
Telix Pharmaceuticals (TLX) expands its artificial intelligence (AI) capability through the acquisition of Vienna-based Dedicaid, a spin-off of Medical University Vienna Telix says Dedicaid’s core asset, a clinical decision support softw... |
themarketherald.com.au | TLX | 11 months ago |
Guess which ASX 200 healthcare stock just made a ‘powerful’ AI acquisition
Stock in S&P/ASX 200 Index (ASX: XJO) biopharma company Telix Pharmaceuticals Ltd (ASX: TLX) is in the red on news of a major artificial intelligence (AI) acquisition. The developer of diagnostic and therapeutic radiopharmaceuticals ha... |
Motley Fool | TLX | 11 months ago |
ASX Today: Stocks to watch on Thursday
The ASX is on Thursday expected to follow the US Dow Jones index, which declined overnight following another slump in the banking sector. The dip comes from troubles surrounding the First Republic Bank, which has seen its shares fall mor... |
themarketherald.com.au | TLX | 11 months ago |
Here are the top 10 ASX 200 shares today
After starting off deep in the red, the S&P/ASX 200 Index (ASX: XJO) regained some ground to close 0.08% lower at 7,316.3 points. Its wobbly performance came amid the release of the latest Australian consumer price index (CPI) data, co... |
Motley Fool | TLX | 11 months ago |
Here are the top 10 ASX 200 shares today
The S&P/ASX 200 Index (ASX: XJO) closed the week in the red, falling 0.43% in Fridayâs session to close at 7,330.4 points. That leaves it 0.42% lower than it was this time last week. Weighing the index down today were its two largest... |
Motley Fool | TLX | 1 year ago |
Why Link, Lynas, Telix, and Whitehaven Coal shares are pushing higher today
The S&P/ASX 200 Index (ASX: XJO) has followed Wall Streetâs lead and is on course to end the week with a decline. In afternoon trade, the benchmark index is down 0.4% to 7,335.4 points. Four ASX shares that are not letting that hol... |
Motley Fool | TLX | 1 year ago |
ScoPo’s (actually Iain’s) Powerplays: ASX health stocks fall, Neuren’s DAYBUE drug officially rolling out in US
ASX health stocks fall 0.32% in the past five days, despite rise in broader markets Neuren Pharmaceutical announces its DAYBUE drug officially available in US to treat Rett Syndrome Impedimed quarterly results in line with expectations wit... |
Stockhead | TLX | 1 year ago |
SLA, TLX, EMR: Three ASX shares that hit 52-week highs on Thursday
Highlights: The Australian benchmark index S&P/ASX 200 index, has decreased by 2.64% in the last one-year period. On 20 April, SILK Australia Limited (ASX: SLA) managed to hit its 52-week, closing the trading session at AU$3.000, i... |
Kalkine Media | TLX | 1 year ago |
Here are the top 10 ASX 200 shares today
The S&P/ASX 200 Index (ASX: XJO) traded relatively flat for most of Thursday, finishing the session 0.04% lower at 7,362.2 points. It came on a dismal performance by the S&P/ASX 200 Materials Index (ASX: XMJ). The mining sector tu... |
Motley Fool | TLX | 1 year ago |
Telix reports its first quarter of $100 million in revenue
Australian radiopharmaceutical company Telix (ASX:TLX) has delivered its first $100 million revenue quarter with soaring growth in the US. |
BiotechDispatch | TLX | 1 year ago |
TMH Market Close: ASX closes in the green, but Star Entertainment Group (SGR) drags
The ASX ended the day in the green, but Asian markets didn’t quite cross the line. The ASX 200 closed up 5.3 points or 0.07 per cent to 7365.5 points. In the green Healthcare stock Telix Pharmaceuticals (TLX) was the top-performing... |
themarketherald.com.au | TLX | 1 year ago |